FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

14 results

busulfan
(Busulfan)
Medication Details
Amneal Pharmaceuticals LLC
Usage: Busulfan injection is indicated in combination with cyclophosphamide as a conditioning regimen before allogeneic hematopoietic progenitor cell transplantation in patients with chronic myelogenous leukemia.
Medication Details
Drug Interactions
busulfan
(Busulfan)
Medication Details
Eugia US LLC
Usage: Busulfan injection is indicated for use alongside cyclophosphamide as a conditioning regimen before allogeneic hematopoietic progenitor cell transplantation in patients with chronic myelogenous leukemia.
Medication Details
Drug Interactions
cyclophosphamide
(cyclophosphamide)
Medication Details
Dr. Reddy's Laboratories Inc.
Usage: Cyclophosphamide is indicated for treating malignant diseases in adults and pediatric patients, including various lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, adenocarcinoma of the ovary, retinoblastoma, and breast carcinoma. It is often used in combination with other antineoplastic agents.
Medication Details
Drug Interactions
cytarabine
(CYTARABINE)
Medication Details
Fresenius Kabi USA, LLC
Usage: Cytarabine Injection is indicated for remission induction in acute non-lymphocytic leukemia in adults and pediatric patients, and for treating acute non-lymphocytic leukemia and blast phase chronic myelocytic leukemia. It is also used intrathecally for prophylaxis and treatment of meningeal leukemia.
Medication Details
Drug Interactions
cytarabine
(Cytarabine)
Medication Details
Meitheal Pharmaceuticals Inc.
Usage: Cytarabine Injection, in combination with other anti-cancer drugs, is indicated for remission induction in acute non-lymphocytic leukemia, acute lymphocytic leukemia, and the blast phase of chronic myelocytic leukemia. It is also used intrathecally for prophylaxis and treatment of meningeal leukemia.
Medication Details
Drug Interactions
dasatinib
(Dasatinib)
Medication Details
Dr. Reddy's Laboratories Inc.
Usage: Dasatinib tablets are indicated for adults with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and those with advanced Ph+ CML or Ph+ acute lymphoblastic leukemia (ALL) who are resistant or intolerant to prior therapy. They are also approved for pediatric patients with Ph+ CML and newly diagnosed Ph+ ALL.
Medication Details
dasatinib
(dasatinib)
Medication Details
Biocon Pharma Inc.
Usage: Dasatinib is indicated for treating adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (CML) in chronic phase, Ph+ CML with resistance to prior therapy, and Ph+ acute lymphoblastic leukemia (ALL). It is also indicated for pediatric patients aged 1 and older with Ph+ CML and newly diagnosed Ph+ ALL.
Medication Details
dasatinib
(Dasatinib)
Medication Details
Apotex Corp.
Usage: Dasatinib tablets are indicated for adults with newly diagnosed Ph+ chronic myeloid leukemia (CML) in chronic phase, resistant or intolerant Ph+ CML, and Ph+ acute lymphoblastic leukemia (ALL). It is also for pediatric patients (1 year and older) with Ph+ CML and newly diagnosed Ph+ ALL with chemotherapy.
Medication Details
Drug Interactions
dasatinib
(dasatinib)
Medication Details
Prasco Laboratories
Usage: Dasatinib tablets are indicated for adults with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (CML), Ph+ CML with resistance/intolerance to prior therapy, and Ph+ acute lymphoblastic leukemia (ALL). They are also indicated for pediatric patients (≥1 year) with Ph+ CML and newly diagnosed Ph+ ALL with chemotherapy.
Medication Details
Drug Interactions
dasatinib
(dasatinib)
Medication Details
Zydus Pharmaceuticals USA Inc.
Usage: Dasatinib tablets are indicated for adults with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase, and for chronic, accelerated, or blast phase Ph+ CML with resistance or intolerance to prior therapy, as well as for Ph+ acute lymphoblastic leukemia (ALL) under similar conditions.
Medication Details

Medications for Leukemia Myelogenous Chronic Bcrabl Positive

busulfan

busulfan

cyclophosphamide

cytarabine

cytarabine

dasatinib

dasatinib

dasatinib

dasatinib

dasatinib